Cargando…

Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide

Conversion of amyloid fibrils by many peptides/proteins involves cytotoxic helix-rich oligomers. However, their toxicity and biophysical studies remain largely unknown due to their highly dynamic nature. To address this, we chose two helical peptides (melittin, Mel and pancreatic polypeptide, PP) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Pradeep K., Ghosh, Dhiman, Tewari, Debanjan, Mohite, Ganesh M., Carvalho, Edmund, Jha, Narendra Nath, Jacob, Reeba S., Sahay, Shruti, Banerjee, Rinti, Bera, Amal K., Maji, Samir K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372375/
https://www.ncbi.nlm.nih.gov/pubmed/25803428
http://dx.doi.org/10.1371/journal.pone.0120346
_version_ 1782363172233019392
author Singh, Pradeep K.
Ghosh, Dhiman
Tewari, Debanjan
Mohite, Ganesh M.
Carvalho, Edmund
Jha, Narendra Nath
Jacob, Reeba S.
Sahay, Shruti
Banerjee, Rinti
Bera, Amal K.
Maji, Samir K.
author_facet Singh, Pradeep K.
Ghosh, Dhiman
Tewari, Debanjan
Mohite, Ganesh M.
Carvalho, Edmund
Jha, Narendra Nath
Jacob, Reeba S.
Sahay, Shruti
Banerjee, Rinti
Bera, Amal K.
Maji, Samir K.
author_sort Singh, Pradeep K.
collection PubMed
description Conversion of amyloid fibrils by many peptides/proteins involves cytotoxic helix-rich oligomers. However, their toxicity and biophysical studies remain largely unknown due to their highly dynamic nature. To address this, we chose two helical peptides (melittin, Mel and pancreatic polypeptide, PP) and studied their aggregation and toxicity. Mel converted its random coil structure to oligomeric helical structure upon binding to heparin; however, PP remained as helix after oligomerization. Interestingly, similar to Parkinson’s associated α-synuclein (AS) oligomers, Mel and PP also showed tinctorial properties, higher hydrophobic surface exposure, cellular toxicity and membrane pore formation after oligomerization in the presence of heparin. We suggest that helix-rich oligomers with exposed hydrophobic surface are highly cytotoxic to cells irrespective of their disease association. Moreover as Mel and PP (in the presence of heparin) instantly self-assemble into stable helix-rich amyloidogenic oligomers; they could be represented as models for understanding the biophysical and cytotoxic properties of helix-rich intermediates in detail.
format Online
Article
Text
id pubmed-4372375
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43723752015-04-04 Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide Singh, Pradeep K. Ghosh, Dhiman Tewari, Debanjan Mohite, Ganesh M. Carvalho, Edmund Jha, Narendra Nath Jacob, Reeba S. Sahay, Shruti Banerjee, Rinti Bera, Amal K. Maji, Samir K. PLoS One Research Article Conversion of amyloid fibrils by many peptides/proteins involves cytotoxic helix-rich oligomers. However, their toxicity and biophysical studies remain largely unknown due to their highly dynamic nature. To address this, we chose two helical peptides (melittin, Mel and pancreatic polypeptide, PP) and studied their aggregation and toxicity. Mel converted its random coil structure to oligomeric helical structure upon binding to heparin; however, PP remained as helix after oligomerization. Interestingly, similar to Parkinson’s associated α-synuclein (AS) oligomers, Mel and PP also showed tinctorial properties, higher hydrophobic surface exposure, cellular toxicity and membrane pore formation after oligomerization in the presence of heparin. We suggest that helix-rich oligomers with exposed hydrophobic surface are highly cytotoxic to cells irrespective of their disease association. Moreover as Mel and PP (in the presence of heparin) instantly self-assemble into stable helix-rich amyloidogenic oligomers; they could be represented as models for understanding the biophysical and cytotoxic properties of helix-rich intermediates in detail. Public Library of Science 2015-03-24 /pmc/articles/PMC4372375/ /pubmed/25803428 http://dx.doi.org/10.1371/journal.pone.0120346 Text en © 2015 Singh et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Singh, Pradeep K.
Ghosh, Dhiman
Tewari, Debanjan
Mohite, Ganesh M.
Carvalho, Edmund
Jha, Narendra Nath
Jacob, Reeba S.
Sahay, Shruti
Banerjee, Rinti
Bera, Amal K.
Maji, Samir K.
Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide
title Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide
title_full Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide
title_fullStr Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide
title_full_unstemmed Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide
title_short Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide
title_sort cytotoxic helix-rich oligomer formation by melittin and pancreatic polypeptide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372375/
https://www.ncbi.nlm.nih.gov/pubmed/25803428
http://dx.doi.org/10.1371/journal.pone.0120346
work_keys_str_mv AT singhpradeepk cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT ghoshdhiman cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT tewaridebanjan cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT mohiteganeshm cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT carvalhoedmund cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT jhanarendranath cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT jacobreebas cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT sahayshruti cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT banerjeerinti cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT beraamalk cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide
AT majisamirk cytotoxichelixricholigomerformationbymelittinandpancreaticpolypeptide